Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...

A resurfaced CIA document reveals that US intelligence once examined research hinting at a potential cancer treatment more ...

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...

Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its primary objective. The results of the clinical trial mark a setback for the ...

Roche stock tumbled Monday — giving way to steeper losses for Olema — after its oral breast cancer treatment failed in ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a ...

Prolia works similarly to alendronate by slowing down the cells that break down bone, called osteoclasts. Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so ...

Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper deal and raising £8.5 million.

As Jessica Huffman underwent a double mastectomy and chemotherapy for invasive breast cancer two years ago, she felt mostly normal for most of the treatment. The exception was the loss of her long ...

Bristol Myers Squibb on Monday said its experimental drug for a rare form ​of blood cancer improved survival in a late‑stage ...